Earnings call transcript: Medical Facilities Q3 2025 sees revenue rise 7.5%

Published 06/11/2025, 15:16
Earnings call transcript: Medical Facilities Q3 2025 sees revenue rise 7.5%

Medical Facilities Corporation (MFC) reported a notable increase in its financial performance for the third quarter of 2025, with a 7.5% rise in facility service revenue to $82.6 million. Despite this growth, the company’s stock experienced a decline, closing 2.61% lower at $13.42, following a decrease of $0.37 from the previous close. The earnings call highlighted the company’s focus on operational efficiency and strategic initiatives, although market reaction was mixed.

Key Takeaways

  • Facility service revenue increased by 7.5% to $82.6 million.
  • Income from operations rose 28.4% to $12.2 million.
  • The company’s stock fell by 2.61% in post-earnings trading.
  • Medical Facilities remains free of corporate-level bank debt.
  • The company is actively recruiting new medical specialists.

Company Performance

Medical Facilities Corporation demonstrated strong financial performance in Q3 2025, with a significant increase in both income from operations and EBITDA. The company reported a 28.4% rise in income from operations, reaching $12.2 million, and a 17.7% increase in EBITDA to $16.1 million. This performance was driven by a strategic shift towards higher acuity surgical procedures and favorable case and payer mix, which contributed to revenue growth despite a decline in inpatient cases.

Financial Highlights

  • Revenue: $82.6 million, up 7.5% year-over-year
  • Income from operations: $12.2 million, up 28.4%
  • EBITDA: $16.1 million, up 17.7%
  • Surgical case volumes: up 1.1%
  • Outpatient cases: up 3.3%, inpatient cases: down 5.3%

Earnings vs. Forecast

The earnings per share (EPS) forecast was set at $0.21. The actual EPS results were not disclosed in the earnings call summary, but the revenue exceeded the forecast of $76.7 million, coming in at $82.6 million. This represents a revenue beat, which is significant given the positive EPS revisions in the past 90 days.

Market Reaction

Despite the strong financial results, Medical Facilities’ stock price fell by 2.61% to $13.42 following the earnings announcement. This decline could be attributed to market expectations or broader sector trends, as the stock remains within its 52-week range of $13.77 to $17.97.

Outlook & Guidance

Looking forward, Medical Facilities plans to continue its focus on enhancing surgical facility performance and maintaining strong cash reserves. The company’s strategic initiatives include recruiting additional pain doctors and spine surgeons to support growth. The firm also remains committed to its share repurchase program, having repurchased 4.7 million shares for $56.8 million.

Executive Commentary

Jason Redman, President and CEO, emphasized the company’s strong quarterly performance, stating, "We had a strong quarter with growth in income from operations and EBITDA." CFO David Watson highlighted the company’s financial stability, noting, "We remained free of corporate-level bank debt."

Risks and Challenges

  • Decline in inpatient cases by 5.3% could impact future revenue.
  • Increasing costs in drugs and supplies, up 10.5%, may affect margins.
  • The competitive landscape in pain management, with a 15.4% decrease in cases.
  • Economic uncertainties and potential changes in healthcare regulations.
  • Dependence on high payer rates for revenue growth.

Q&A

No questions were asked during the earnings call, which may indicate either a comprehensive presentation or a lack of immediate concerns from analysts.

Full transcript - Medical Facilities Corporation (DR) Q3 2025:

Rob, Conference Call Moderator: Good morning, everyone. Welcome to Medical Facilities Corporation’s 2025 third-quarter earnings call. After management’s remarks, this call will include a question-and-answer session when qualified equity analysts may ask questions. Before turning the call over to management, listeners are reminded that today’s call may contain forward-looking statements within the meaning of the safe harbor provisions of Canadian provincial securities laws. Forward-looking statements involve risks and uncertainties, and undue reliance should not be placed on such statements. Certain material factors or assumptions are applied in making forward-looking statements, and actual results may differ materially from those expressed or implied in such statements. For additional information, please consult the MD&A for this quarter, the risk factor section of the annual information form, and Medical Facilities’ other filings with Canadian securities regulators. Medical Facilities does not undertake to update any forward-looking statements except as required by law.

Such statements speak only as of the date made. I would now like to turn the meeting over to Mr. Jason Redman, President and CEO of Medical Facilities. Please go ahead, Mr. Redman.

Jason Redman, President and CEO, Medical Facilities Corporation: Good morning, everyone, and thank you for joining us today. On the call with me is our Chief Financial Officer, David Watson. This morning, we reported our third-quarter results. Our news release, financial statements, and MD&A are available on our website and have been filed on SEDAR+. Please note that the income statement variances discussed by Dave and I this morning are for continuing operations and exclude government stimulus amounts from last year. As usual, all dollar amounts are in US dollars unless otherwise specified. We had a strong quarter with growth in income from operations and EBITDA driven by increased facility service revenue at each of our highly rated surgical facilities. A big contributor in the quarter was Sioux Falls Specialty Hospital, where, as expected, surgical case volumes had a solid rebound following the planned relocation of a key referral group’s clinic earlier in the year.

While the clinic move had a temporary negative impact on volumes in the second quarter, the transition is now behind them. We were pleased to see that the clinic was back to business as usual by the third quarter. On a consolidated basis, facility service revenue was up 7.5% in the quarter, benefiting from the favorable impacts of case and payer mix, higher payer rates, and increased surgical case volumes. Income from operations was up 28.4%, and EBITDA increased 17.7% in the quarter. On the topic of our hospitals, I wanted to give a quick shout-out to the folks at Sioux Falls and Arkansas, both of which received five-star ratings in September for nurse communications based on CMS’s Hospital Consumer Assessment of Healthcare Providers and Systems data.

Finally, on the capital allocation front, we returned $5.6 million to shareholders in the quarter through the repurchase of 514,200 common shares under our normal course issuer bid. For the first nine months of the year, share repurchases under both our normal course and substantial issuer bids totaled about 4.7 million shares, representing $56.8 million being returned to shareholders and a 20% reduction in our outstanding share count. Even after these significant returns, our corporate cash position at quarter-end remained strong at $34.5 million. With that, I’ll turn the call over to David to review our financial results in more detail. David.

David Watson, Chief Financial Officer, Medical Facilities Corporation: Thank you, Jason. Good morning, everyone. Starting with the top line, we had facility service revenue of $82.6 million for the quarter, which is an increase of 7.5%. As Jason mentioned, the increase was mainly due to the combined impact of case and payer mix. In addition, payer rate increases resulted in higher reimbursements per surgical case, and our surgical case volumes were up 1.1% for the quarter. Outpatient cases were up 3.3%, but inpatient cases decreased by 5.3%, and observation cases were down 3.1%. Pain management cases were down 15.4% in the quarter, mainly due to decreases at Arkansas Surgical Hospital and Sioux Falls Specialty Hospital. Pain cases were down at ASH following the departure of a pain doctor in Q4 of last year.

As we said in our call last quarter, a new pain doctor started at ASH this August, and a new spine surgeon joined a referral group’s practice in September. Pain cases at Sioux Falls were impacted by the departure of a pain physician in the second quarter. The hospital is actively recruiting for both a pain doctor and a spine surgeon. Our operating expenses for the quarter were about $3.1 million higher than prior year, as increases to consolidated salaries and benefits and to drugs and supplies more than offset our lower G&A expenses. Consolidated salaries and benefits increased 6.2%, primarily reflecting annual merit adjustments, market wage pressures, and higher benefit costs related to increased health plan utilization.

This was partially offset by a reduction in salaried physicians and clinical staff, including one physician who transitioned from being an employee to joining a referring practice and becoming an owner in the hospital at the end of last year. Drugs and supplies rose by 10.5%, mainly reflecting a shift in case mix toward higher acuity procedures. This increase was partially offset by improved implant cost savings achieved at certain facilities. Higher surgical case volumes also contributed to the increase, while higher vendor rebates provided a modest offset. Meanwhile, G&A expenses were down 4.9%, largely due to lower corporate-level costs for share-based compensation plans, in addition to savings realized in professional fees and contracted services. These reductions were partly offset by higher repairs and maintenance expenses, along with increased recruiting costs and physician guarantees.

Looking at our profitability for the quarter, and again, excluding the government stimulus income last year, income from operations increased 28.4% to $12.2 million, and EBITDA increased 17.7% to $16.1 million. Turning to our balance sheet, at the end of September, we had consolidated net working capital of $43 million, with cash and cash equivalents of $46.8 million. This compares to net working capital of $76.4 million and cash and cash equivalents of $108.5 million at the end of 2024. The decrease in consolidated net working capital was primarily driven by the completion of the substantial issuer bid in March, which reduced cash and cash equivalents by $43.7 million. Other significant drivers were the $14.4 million tax payment in April related to the gain on sale of Black Hills Surgical Hospital, and $14.8 million used to repurchase shares under our normal course issuer bid.

We remained free of corporate-level bank debt, having fully repaid our corporate credit facility near the end of last year. As we announced last quarter, on August 6th, we executed a new credit agreement with Canadian Imperial Bank of Commerce. The agreement is for a $40 million revolving credit facility with an option to increase the facility by up to $25 million, contingent upon meeting specified conditions. This concludes our prepared remarks. We would now like to open the call up for questions. Operator?

Rob, Conference Call Moderator: Yes, thank you very much. We will now begin the question and answer session. Should you have a question, please press the star followed by the one on your touch-tone phone. You will hear a prompt that your hand has been raised. Should you wish to decline from the following process, please press the star followed by the two. If you are using a speakerphone, please lift the handset before pressing any keys. We will wait for one minute then for everyone to queue up for questions. Just please press star one if you have a question. Okay. It seems we have no questions at this time. As a quick reminder, you just need to press star one to ask a question. Okay. I believe we have no questions at this time. Okay. I will now turn the call back to Mr. Redman then for closing remarks. Please go ahead.

Jason Redman, President and CEO, Medical Facilities Corporation: Thank you, Rob. Thanks to everyone joining us this morning. We appreciate your continued support and look forward to keeping you updated on our progress. Have a great day.

Rob, Conference Call Moderator: Ladies and gentlemen, this concludes today’s conference call. Thank you for your participation. You may now disconnect.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.